# David Geldmacher

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-geldmacher/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,195 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 56 |
| i10-index | 146 |
| Last Known Institution | University of Alabama at Birmingham |
| OpenAlex ID | https://openalex.org/A5063637830 |
| ORCID iD | 0000-0003-2958-1876 |
| Works | 282 |

## Researcher papers

- [Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs](https://scholariq.org/papers/development-of-cognitive-instruments-for-use-in-clinical-trials-of-antidementia/)
- [DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease](https://scholariq.org/papers/dna-replication-precedes-neuronal-cell-death-in-alzheimer-s-disease/)
- [Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain](https://scholariq.org/papers/ectopic-cell-cycle-proteins-predict-the-sites-of-neuronal-cell-death-in/)
- [Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.](https://scholariq.org/papers/development-of-cognitive-instruments-for-use-in-clinical-trials-of-antidementia-2/)
- [Predicting Alzheimer’s disease progression using multi-modal deep learning approach](https://scholariq.org/papers/predicting-alzheimer-s-disease-progression-using-multi-modal-deep-learning/)
- [Efficacy and Tolerability of Donepezil in Vascular Dementia](https://scholariq.org/papers/efficacy-and-tolerability-of-donepezil-in-vascular-dementia/)
- [Apathy in Alzheimer's Disease](https://scholariq.org/papers/apathy-in-alzheimer-s-disease/)
- [Conduction aphasia as a function of the dominant posterior perisylvian cortex](https://scholariq.org/papers/conduction-aphasia-as-a-function-of-the-dominant-posterior-perisylvian-cortex/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)

## Researcher university

- [University of Alabama at Birmingham](https://scholariq.org/institutions/university-of-alabama-at-birmingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.